These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 3910796)

  • 21. In vitro susceptibility of recently isolated gram-negative bacteria to gentamicin, sisomicin, tobramycin, and amikacin.
    Knothe H
    J Infect Dis; 1976 Nov; 134 SUPPL():S271-4. PubMed ID: 825585
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vitro activity of sisomicin, an aminoglycoside antibiotic, against clinical isolates.
    Stewart D; Bodey GP
    J Antibiot (Tokyo); 1975 Feb; 28(2):149-55. PubMed ID: 234415
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Comparison of the antibacterial effects of gentamycin, tobramycin, dibekacin and amikacin in urinary germs].
    Rothenberger K; Friesen A; Streifinger W; Hofstetter A
    Fortschr Med; 1981 Oct; 99(40):1669-72. PubMed ID: 7298004
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Kinetics of antimicrobial activity.
    Vogelman B; Craig WA
    J Pediatr; 1986 May; 108(5 Pt 2):835-40. PubMed ID: 3701535
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 1-N HAPA gentamicin B, a new aminoglycoside active against gentamicin resistant isolates--activity compared to other aminoglycosides.
    Neu HC; Fu KP
    J Antibiot (Tokyo); 1978 May; 31(5):385-93. PubMed ID: 27494
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vitro susceptibility of gentamicin and/or tobramycin resistant gram-negative bacilli to seven aminoglycosides.
    Watanakunakorn C; Kauffman CA
    Infection; 1978; 6(3):111-5. PubMed ID: 98451
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro activity of isepamicin and other aminoglycosides against clinical isolates of Gram-negative bacteria causing nosocomial bloodstream infections.
    Tsai TY; Chang SC; Hsueh PR; Feng NH; Wang JT
    J Microbiol Immunol Infect; 2007 Dec; 40(6):481-6. PubMed ID: 18087627
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Dibekacin--a novel aminoglycoside antibioticl. Antimicrobial activity and parallel resistance in vitro].
    Schassan HH; Witt U
    Arzneimittelforschung; 1979; 29(2):174-8. PubMed ID: 582126
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Bactericidal activity of aminosides in a static system and in a dynamic model].
    Drugeon HB; Maurisset B; Courtieu AL
    Nouv Presse Med; 1979 Oct; 8(42):3403-6. PubMed ID: 395504
    [No Abstract]   [Full Text] [Related]  

  • 30. Effect of some aminoglycosides upon a drug dependent Escherichia coli strain.
    Gadó I; Dumbovich I
    Acta Microbiol Acad Sci Hung; 1975; 22(2):95-104. PubMed ID: 1092134
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Susceptibility of current clinical isolates of Pseudomonas aeruginosa and enteric gram-negative bacilli to amikacin and other aminoglycoside antibiotics.
    Dámaso D; Moreno-López M; Martínez-Beltrán J; García-Iglesias MC
    J Infect Dis; 1976 Nov; 134 SUPPL():S394-90. PubMed ID: 825591
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Comparative effects of netilmicin and 4 other aminoglycosides on 1028 bacterial strains isolated in a hospital milieu].
    Reynaud A; Derriennic M; Courtieu AL
    Pathol Biol (Paris); 1985 Mar; 33(3):189-94. PubMed ID: 3892446
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Triangular comparison of the agar diffusion method, the ABAC system and the Sensitre system for determination of bacterial sensitivity to aminoglycoside chemoantibiotics].
    Sala A; Raffaele L; Cappello P
    Quad Sclavo Diagn; 1981 Mar; 17(1):100-8. PubMed ID: 7313065
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Compiled data on aminoglycoside, foremost netilmicin susceptibility of bacterial strains.
    Juhlin I; Tunevall G
    Scand J Infect Dis Suppl; 1980; Suppl 23():39-44. PubMed ID: 6782657
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of effectiveness of aminoglycosides and cephalosporins in gram-negative rods.
    Vrbová E; Uxová M; Výmola F
    Czech Med; 1986; 9(3):148-52. PubMed ID: 3095073
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Minimal antibiotic concentrations of aminoglycosides and beta-lactam antibiotics for some gram-negative bacilli and gram-positive cocci.
    Lorian V; De Freitas CC
    J Infect Dis; 1979 May; 139(5):599-603. PubMed ID: 108345
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bactericidal activity and post-antibiotic effect in vitro of dactimicin alone and in combination with other drugs.
    Debbia E; Schito GC; Stefani S; Nicoletti G
    J Chemother; 1989 Jul; 1(4 Suppl):187-8. PubMed ID: 16312361
    [No Abstract]   [Full Text] [Related]  

  • 38. Fortimicins A and B, new aminoglycoside antibiotics. IV. In vitro study of fortimicin A compared with other aminoglycosides.
    Girolami RL; Stamm JM
    J Antibiot (Tokyo); 1977 Jul; 30(7):564-70. PubMed ID: 19409
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cefotaxime aminoglycoside interactions.
    Pierce MA; Elliott AM; Cobbs CG
    Chemotherapy; 1985; 31(5):336-45. PubMed ID: 4053733
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vitro activity of netilmicin, gentamicin, tobramycin and amikacin against glucose fermenting and nonfermenting bacteria.
    DiPersio JR; Krafczyk TL
    Chemotherapy; 1980; 26(5):323-33. PubMed ID: 7389428
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.